Notably, Trem2 was reported to be a risk gene in AD pathogenesis (Frank et al., 2008; Guerreiro et al., 2013) and its expression is upregulated in animal models of AD (Neumann and Takahashi, 2007; Guerreiro et al., 2013). This evidence concerns the gene TREM2 and Alzheimer disease.